Holen Sie sich die Stockscreener-App
1.62
2.41%
-0.04
Handel nachbörslich:
1.63
0.010
+0.62%
Bluejay Diagnostics Inc Aktie (BJDX) Neueste Nachrichten
Bluejay Diagnostics (BJDX) Stock Skyrockets Over 44% on Nasdaq in Explosive Short-Term Rally - Daily Chhattisgarh News
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Initiates SYMON-II Clinical Study - TipRanks
Bluejay Diagnostics advances sepsis test, plans FDA filing By Investing.com - Investing.com South Africa
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Updat - GuruFocus
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Update | BJDX Stock News - GuruFocus
Bluejay Diagnostics advances sepsis test, plans FDA filing - Investing.com Australia
Bluejay Diagnostics Provides Mid-Year Business And Corporate Update - MarketScreener
Bluejay Diagnostics Slashes Workforce to Just 5 Employees as Cash Burns, Despite Promising Sepsis Trial Data - Stock Titan
Bluejay Diagnostics (NASDAQ:BJDX) Stock Price Up 1.2% – Here’s Why - Defense World
Bluejay Diagnostics announces CTO departure By Investing.com - Investing.com South Africa
Bluejay Diagnostics Announces CTO Departure Effective May 30 - TipRanks
Bluejay Diagnostics announces CTO departure - Investing.com Australia
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Bluejay Diagnostics, Inc. SEC 10-Q Report - TradingView
Bluejay Diagnostics Inc (BJDX) Stock: A Comprehensive 52-Week Review - investchronicle.com
Bluejay Diagnostics Inc (BJDX)’s stock price range in the last year - uspostnews.com
BJDX stock touches 52-week low at $1.6 amid steep annual decline - Investing.com Canada
BJDX stock touches 52-week low at $1.6 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline - Investing.com India
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Breakthrough Sepsis Test Could Predict Patient Mortality Risk, New Study Reveals - Stock Titan
Small Cap Stocks To Watch NowApril 7th - MarketBeat
US Markets Rebound As Global Trade Tensions Persist - Finimize
United States shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com India
Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com UK
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BJDX stock touches 52-week low at $3.01 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $3.01 amid steep annual decline - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
Wall Street Attempts Recovery From Tariff-Driven Losses as US Equity Futures Rise Pre-Bell - TradingView
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jack Kellogg Called The Market Bottom - timothysykes.com
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price - marketscreener.com
Bluejay Diagnostics Sinks Premarket Following Investor Agreement to Exercise Warrants at 'Reduced' Price - marketscreener.com
Bluejay Diagnostics enters into agreement with institutional investors - Medical Buyer
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - NewsBreak: Local News & Alerts
Bluejay Diagnostics (BJDX) Secures $3.7M Through Warrant Exercis - GuruFocus
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - The Manila Times
Bluejay Diagnostics Announces Entry Into Warrant Inducement Transaction For Approximately $3.7 Million In Gross Proceeds - marketscreener.com
Bluejay Diagnostics Raises Fresh $3.7M Capital: New Warrant Deal Strengthens Balance Sheet - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Vermilion Energy Inc. Confirms First Quarter 2025 Release Date and Filing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
'Magnificent 7' stocks continue getting hammered as Trump tariffs drag markets lower - Yahoo Finance
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):